The European Commission’s R&D toolbox in the COVID-19 outbreak includes extended deadlines in Horizon 2020, additional funding opportunities for viral research - and less red tape

Former EU chief science adviser Anne Glover discusses the UK’s handling of the COVID-19 epidemic and if the European Commission is lacking scientific leadership during the crisis

Meetings cancelled, workers sent home, conferences postponed as EU officials and lobbyists try to cope with the pandemic

EU president Charles Michel says there is ‘strong common will’ between G7 countries to deliver coronavirus vaccine, following reports of big-money overture by president Trump to CureVac

Brussels outlines broad cooperation with UK in nuclear research, renewable energy and antimicrobial resistance, and suggests visa waivers for short-term researcher visits

Early stage human trials for vaccine against the virus are ‘days or weeks’ away, but it will take at least 12 – 18 months to complete safety and efficacy tests, and much more money is needed

All universities in Italy, Greece, Denmark, Poland, Ireland and Hungary are closed down, as EU education and research ministers meet online to discuss coordinated response

Funding body seeks programme manager to steer research breakthroughs that will help push Europe to carbon neutrality

A ‘step change in R&D investment’ will see spending double to £22B per annum in 4 years, as government says it will fight COVID-19 pandemic, ‘whatever the cost’